Cancer represents one of the leading causes of death worldwide and early diagnosis is essential to improve the chances of recovery. However, current methods are often expensive, invasive and time-consuming. The detection of circulating tumor cells (CTCs) represents an innovative frontier in cancer diagnosis and prognosis, offering a non-invasive way to monitor disease progression and evaluate the effectiveness of treatments. This thesis explores the development and application of advanced point-of-care (POC) technologies aimed at CTC detection, with a particular focus on the use of fluorescence spectroscopy and plasmonic particles. The goal of these new technologies is to reduce pressure on hospital screening programs by offering rapid, accurate and sensitive tests to improve patient well-being and reduce cancer-related deaths, providing useful results for selecting the best possible treatment .
Il cancro rappresenta una delle principali cause di morte a livello mondiale e la diagnosi precoce è fondamentale per migliorare le possibilità di guarigione. Tuttavia, i metodi attuali sono spesso costosi, invasivi e richiedono molto tempo. Il rilevamento di cellule tumorali circolanti (CTC) rappresenta una frontiera innovativa nella diagnosi e prognosi del cancro, offrendo una modalità non invasiva per monitorare la progressione della malattia e valutare l'efficacia dei trattamenti. Questa tesi esplora lo sviluppo e l'applicazione di tecnologie avanzate per il point-of-care (POC) mirate al rilevamento di CTC, con un'attenzione particolare all'uso della spettroscopia di fluorescenza e delle particelle plasmoniche. L’obiettivo di queste nuove tecologie è quello di ridurre la pressione sui programmi di screening ospedalieri, offrendo test rapidi, accurati e sensibili per migliorare il benessere dei pazienti e ridurre i decessi correlati al cancro, fornendo risultati utili per la selezione del miglior trattamento possibile.
Tecnologie Point of Care per il rilevamento delle cellule tumorali circolanti: innovazioni e prospettive future
BONOMI, GIACOMO
2023/2024
Abstract
Cancer represents one of the leading causes of death worldwide and early diagnosis is essential to improve the chances of recovery. However, current methods are often expensive, invasive and time-consuming. The detection of circulating tumor cells (CTCs) represents an innovative frontier in cancer diagnosis and prognosis, offering a non-invasive way to monitor disease progression and evaluate the effectiveness of treatments. This thesis explores the development and application of advanced point-of-care (POC) technologies aimed at CTC detection, with a particular focus on the use of fluorescence spectroscopy and plasmonic particles. The goal of these new technologies is to reduce pressure on hospital screening programs by offering rapid, accurate and sensitive tests to improve patient well-being and reduce cancer-related deaths, providing useful results for selecting the best possible treatment .| File | Dimensione | Formato | |
|---|---|---|---|
|
Tesi di laurea - Giacomo Bonomi - 2042815.pdf
accesso aperto
Dimensione
722.74 kB
Formato
Adobe PDF
|
722.74 kB | Adobe PDF | Visualizza/Apri |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/70845